Next Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
PI
Next Financial Group's REGN Position: Q4 2021 in Review
Next Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 41% in Q4 2021, buying an estimated $619K and bringing the position to 3,480 shares worth $2.2M. The position accounts for 0.14% of the portfolio, ranked #152.
Next Financial Group first reported a position in REGN in Q3 2014 and has held it in 22 quarters since. 1,079 funds tracked by Wall St. Rank hold REGN as of Q4 2021.
- Next Financial Group held 3,480 shares of Regeneron Pharmaceuticals worth $2.2M as of Q4 2021.
- Next Financial Group bought 1,006 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $619K.
- Regeneron Pharmaceuticals made up 0.14% of Next Financial Group's portfolio in Q4 2021, its #152 holding.
- Next Financial Group first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 22 quarters since.
- 1,079 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.
Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.